Kimia Biosciences

45.07
0.00
(0.00%)
Market Cap
213.20 Cr
EPS
-1.12
PE Ratio
22.65
Dividend Yield
0.00 %
Industry
Healthcare
52 Week High
58.39
52 Week low
37.33
PB Ratio
26.82
Debt to Equity
16.69
Add Ratio

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Competitors LTP Market Cap (₹ Cr.) P/E Ratio Revenue (₹ Cr.) YoY Revenue Growth % Net Profit (₹ Cr.) YoY Profit Growth % RSI
1,663.10 3,99,033.40 33.68 49,887.20 12.06 9,648 13.77 47.46
5,528.85 1,46,773.60 71.18 8,184.00 0.89 1,600 64.53 40.99
1,452.30 1,17,289.79 23.41 26,520.70 14.17 4,155 47.38 48.78
3,074.90 1,04,068.59 55.61 10,785.70 11.59 1,656 13.54 47.28
1,098.20 91,635.00 17.35 28,905.40 12.36 5,578 1.69 31.30
1,967.00 89,734.06 31.45 20,141.50 19.94 1,936 38.82 44.40
2,167.50 89,423.88 44.67 10,615.60 19.57 1,942 -16.38 33.38
885.05 89,056.74 19.97 19,831.50 13.82 3,831 29.92 45.15
1,112.35 64,605.47 17.97 29,559.20 17.55 3,169 -10.04 42.48
30,389.70 64,575.99 48.58 6,097.20 10.80 1,201 16.01 58.42
Growth Rate
Revenue Growth
-17.89 %
Net Income Growth
-43.62 %
Cash Flow Change
314.62 %
ROE
836.82 %
ROCE
-61.45 %
EBITDA Margin (Avg.)
-137.59 %

Yearly Financial Results

Annual Financials
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
TTM
Revenue
2
0
2
77
95
107
135
126
130
107
112
Expenses
4
4
2
74
88
102
124
124
134
105
95
EBITDA
-1
-3
-0
3
7
5
11
2
-4
1
17
Operating Profit %
-110 %
-1,759 %
-67 %
3 %
6 %
4 %
6 %
1 %
-4 %
-0 %
15 %
Depreciation
0
0
0
1
1
2
2
3
3
3
3
Interest
0
1
0
1
2
3
3
4
4
5
4
Profit Before Tax
-2
-4
-1
2
4
1
6
-5
-12
-7
10
Tax
0
0
-0
-0
0
-0
0
-1
-3
-2
0
Net Profit
-2
-4
-1
2
4
1
5
-4
-9
-5
9
EPS in ₹
-2.31
-5.49
-1.26
1.14
2.64
0.33
1.08
-0.78
-1.98
-1.12
2.00

Balance Sheet

Balance Sheet
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Total Assets
5
4
12
58
65
86
107
110
121
100
Fixed Assets
3
3
7
13
16
18
28
35
34
32
Current Assets
1
1
2
43
48
61
72
73
83
61
Capital Work in Progress
0
0
3
3
2
6
6
0
1
1
Investments
0
0
0
0
0
0
0
0
0
0
Other Assets
1
1
2
43
48
62
73
74
87
68
Total Liabilities
5
4
12
58
65
86
107
110
121
100
Current Liabilities
4
1
7
31
30
39
51
62
76
69
Non Current Liabilities
1
7
9
25
29
34
37
33
40
30
Total Equity
0
-4
-5
2
6
13
18
15
6
0
Reserve & Surplus
-7
-11
-12
-2
2
9
14
10
1
-4
Share Capital
7
7
7
2
2
5
5
5
5
5

Cash Flow

Cash Flow
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Net Cash Flow
0
0
0
1
-1
0
0
-0
0
0
Investing Activities
0
-0
-6
-2
-2
-9
-14
-1
-3
-2
Operating Activities
0
-6
-1
-7
-3
0
6
8
-7
15
Financing Activities
-0
6
7
10
4
9
8
-8
10
-13

Share Holding

% Holding
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Promoter
74.94 %
74.94 %
74.94 %
74.94 %
74.94 %
74.94 %
74.94 %
74.94 %
74.94 %
74.94 %
74.94 %
74.94 %
74.94 %
74.94 %
74.94 %
74.94 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
DIIs
0.38 %
0.38 %
0.38 %
0.38 %
0.38 %
0.38 %
0.38 %
0.38 %
0.38 %
0.38 %
0.38 %
0.38 %
0.38 %
0.38 %
0.38 %
0.38 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
23.16 %
23.15 %
23.15 %
23.09 %
23.16 %
0.00 %
23.20 %
23.11 %
23.10 %
23.04 %
23.04 %
23.04 %
23.05 %
23.05 %
23.03 %
22.94 %
Others
1.52 %
1.52 %
1.52 %
1.59 %
1.51 %
24.68 %
1.48 %
1.57 %
1.58 %
1.64 %
1.64 %
1.64 %
1.63 %
1.63 %
1.65 %
1.74 %
No of Share Holders
11,912
12,192
12,173
12,212
12,510
12,454
12,399
12,243
12,201
12,147
12,118
12,063
12,110
12,023
12,179
12,231

Dividend History

Dividends per share (FY)
Dividend yield (FY) %

No dividends have been distributed by the company in the past 10 years

Corporate Action

Announcements

Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
5 days ago
Non-Applicability Of Corporate Governance Report As Per Regulation 27(2) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 Pursuant To Regulation 15 Of SEBI (Listing Obligatio
Feb 21, 2025, 18:18
Newspaper Publication Of Un-Audited Financial Results For The Quarter And Nine Months Ended On 31St December 2024 Under Regulation 47 Of SEBI (Listing Obligations And Disclosure Requirements) Regulati
Feb 14, 2025, 14:59
Integrated Filing (Financial)
Feb 13, 2025, 18:44
Integrated Filing (Financial) For The Quarter And Nine Months Ended 31St December 2024
Feb 13, 2025, 18:24
Board Meeting Outcome for Outcome Of The Board Meeting Held On Thursday February 13 2025 For Unaudited Financial Results For The Quarter And Nine Months Ended 31St December 2024 Along With The Limited
Feb 13, 2025, 18:18
Board Meeting Intimation for Intimation Of Board Meeting Dated February 13 2025
Feb 07, 2025, 18:15
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Jan 30, 2025, 18:14
Compliance Under Regulation 76 Of SEBI (Depositories And Participants) Regulations 2018 For The Quarter Ended 31St December 2024
Jan 29, 2025, 13:18
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Jan 28, 2025, 18:41
Compliance Under Regulation 76 Of SEBI (Depositories And Participants) Regulations 2018
Jan 28, 2025, 18:38
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Jan 28, 2025, 16:38
Appointment of Company Secretary and Compliance Officer
Jan 28, 2025, 16:08
Regulation 13(3) For The Statement Of Investor Complaints
Jan 22, 2025, 24:10
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
Jan 15, 2025, 16:52
Scrutiniser Report
Dec 31, 2024, 17:54
Chairman Speech
Dec 30, 2024, 23:26
Closure of Trading Window
Dec 30, 2024, 18:09
Shareholder Meeting / Postal Ballot-Outcome of AGM
Dec 30, 2024, 17:49
Annual Report_2023-24
Dec 13, 2024, 18:36
Announcement under Regulation 30 (LODR)-Newspaper Publication
Dec 11, 2024, 17:44
Correction In The Intimation Of 31St Notice Of AGM Dated 30.12.2024
Dec 11, 2024, 17:35
AGM Notice For The FY 2023-24
Dec 09, 2024, 18:56
31St Annual General Meeting ('AGM') Of The Company Is Scheduled To Be Held On Monday, December 30, 2024 At 04.00 Pm (IST) Through Video Conferencing/ Other Audio Visual Means ('VC/OAVM')
Dec 07, 2024, 19:23
Board Meeting Outcome for Revised Outcome Of Board Meeting Dated 05.12.2024
Dec 06, 2024, 15:55
Board Meeting Outcome for Outcome Of Board Meeting Under Regulation 30 Of SEBI (Listing Obligations And DisclosureRequirements), Regulations 2015.
Dec 05, 2024, 17:25
Board Meeting Intimation for Intimation For Board Meeting To Approve Directors Report And AGM Notice For The FY Ended March 31, 2024.
Nov 29, 2024, 21:28
Announcement under Regulation 30 (LODR)-Newspaper Publication
Nov 18, 2024, 23:39
Results For The Half Financial Year September 2024
Nov 14, 2024, 21:25
Results_Financial Statement Ending On 30 September 2024
Nov 14, 2024, 20:43
Appointment of Company Secretary and Compliance Officer
Nov 14, 2024, 20:37
Board Meeting Outcome for Outcome Of Board Meeting Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements), Regulations 2015.
Nov 14, 2024, 19:51
Board Meeting Intimation for Notice Of Board Meeting - November 14, 2024
Nov 12, 2024, 15:15
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Oct 10, 2024, 09:02
Closure of Trading Window
Sep 30, 2024, 13:30
Clarification Letter
Sep 17, 2024, 16:14
Intimation Of Approval For Extension Of Time To Conduct Annual General Meeting
Sep 16, 2024, 16:06
Intimation Under Regulation 30 Of SEBI (LODR) Regulations, 2015 - Award Of Contract
Sep 16, 2024, 15:37
Unaudited Financial Results For The Quarter Ended On 30Th June2024
Aug 20, 2024, 20:09
Announcement under Regulation 30 (LODR)-Newspaper Publication
Aug 20, 2024, 19:16
Unaudited Quarterly Financial Results For The Quarter Ended On 30Th June,2024.
Aug 20, 2024, 18:38
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
Aug 12, 2024, 19:43
Disclosures under Reg. 10(6) of SEBI (SAST) Regulations, 2011
Aug 12, 2024, 19:41
Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance Officer
Aug 12, 2024, 17:00
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
Aug 12, 2024, 14:47
Intimation Under Regulation 30 Of SEBI (Listing Obligation And Disclosure Requirements) Regulations, 2015 For Filing Of Quality Product For Benfotiamine In European Union- Bulgaria.
Aug 09, 2024, 12:29
Board Meeting Intimation for Intimation Of Board Meeting For Adoption Of Un-Audited Financial Results For The Quarter Ended June 30, 2024.
Aug 06, 2024, 17:15
Disclosures under Reg. 10(5) in respect of acquisition under Reg. 10(1)(a) of SEBI (SAST) Regulations, 2011
Aug 03, 2024, 16:28
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Aug 02, 2024, 16:06
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Jul 30, 2024, 12:12

Company Filings to Exchanges

Technical Indicators

RSI(14)
Neutral
49.07
ATR(14)
Less Volatile
4.34
STOCH(9,6)
Neutral
73.10
STOCH RSI(14)
Neutral
53.44
MACD(12,26)
Bullish
0.09
ADX(14)
Weak Trend
12.28
UO(9)
Bearish
54.27
ROC(12)
Downtrend And Accelerating
-1.81
WillR(14)
Neutral
-38.91